Rochester Medical Corp (ROCM) Tops Q2 EPS by 3c

Rochester Medical Corp (NASDAQ: ROCM) reported Q2 EPS of $0.07, $0.03 better than the analyst estimate of $0.04. Revenue for the quarter came in at $15.25 million versus the consensus estimate of $16.93 million.

For earnings history and earnings-related data on Rochester Medical Corp (ROCM) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
• Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions